Trans-sialidase-based vaccine candidate protects against Trypanosoma cruzi infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype.
Oncotarget
; 8(35): 58003-58020, 2017 Aug 29.
Article
em En
| MEDLINE
| ID: mdl-28938533
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article